160 related articles for article (PubMed ID: 30478746)
1. The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines.
Choi HS; Kim YK; Yun PY
Mol Biol Rep; 2019 Feb; 46(1):617-625. PubMed ID: 30478746
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic effect of CKD-602 (Camtobell) on oral squamous cell carcinoma cell lines.
Ok YJ; Myoung H; Kim YK; Lee JH; Kim MJ; Yun PY
Oral Oncol; 2009 Mar; 45(3):266-72. PubMed ID: 18715816
[TBL] [Abstract][Full Text] [Related]
4. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
[TBL] [Abstract][Full Text] [Related]
5. The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.
Khalil A; Jameson MJ
Drugs R D; 2017 Dec; 17(4):545-555. PubMed ID: 28828595
[TBL] [Abstract][Full Text] [Related]
6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
7. The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines.
Kim MJ; Lee JH; Kim YK; Myoung H; Yun PY
Cancer Lett; 2007 Jan; 245(1-2):284-92. PubMed ID: 16513256
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
Choi HS; Kim YK; Yun PY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
[TBL] [Abstract][Full Text] [Related]
10. Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines.
Choi HS; Kim YK; Hwang KG; Yun PY
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255409
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines.
Shen J; Huang C; Jiang L; Gao F; Wang Z; Zhang Y; Bai J; Zhou H; Chen Q
Biochem Pharmacol; 2007 Jun; 73(12):1901-9. PubMed ID: 17445779
[TBL] [Abstract][Full Text] [Related]
12. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
13. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
[TBL] [Abstract][Full Text] [Related]
14. The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines.
Jo DW; Kim YK; Yun PY
J Korean Assoc Oral Maxillofac Surg; 2016 Dec; 42(6):337-344. PubMed ID: 28053903
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
[TBL] [Abstract][Full Text] [Related]
16. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway.
Huang C; Yu Y
Med Sci Monit; 2017 Mar; 23():1507-1513. PubMed ID: 28355175
[TBL] [Abstract][Full Text] [Related]
18. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
[TBL] [Abstract][Full Text] [Related]
19. EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines.
Hiraishi Y; Wada T; Nakatani K; Tojyo I; Matsumoto T; Kiga N; Negoro K; Fujita S
Pathol Oncol Res; 2008 Mar; 14(1):39-43. PubMed ID: 18347929
[TBL] [Abstract][Full Text] [Related]
20. Autophagy induction by low-dose cisplatin: the role of p53 in autophagy.
Cho KH; Park JH; Kwon KB; Lee YR; So HS; Lee KK; Lee SY; Moon SR; Yang SH
Oncol Rep; 2014 Jan; 31(1):248-54. PubMed ID: 24173208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
